North America’s largest coke plant hugs the west bank of Pennsylvania’s Monongahela River, belching out emissions from turning superheated coal into a carbon-rich fuel. Researchers say the children at Clairton Elementary School about a mile away pay the price. They discovered the students there and at other elementary schools near major pollution sites in Pennsylvania…
Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in Silicon Valley. The post “Precision Med Has Evolved as Badly As I Expected” And OtherTakeaways From Former FDA Commissioner At PMWC appeared first…
When every metric is treated as important, nothing actually stands out. Leaders spend more time interpreting data than acting on it. And in a system as complex as healthcare, delays in decision-making can have real operational and financial consequences. The post The Illusion of Visibility: Why More Data Doesn’t Mean Better Decisions appeared first on…
Healthcare providers and vendors are learning the hard way that hackers are relentless and resourceful, constantly adjusting tactics and tools and using new technology, including AI, to launch more sophisticated attacks. The post Healthcare’s Cybersecurity Crisis: Why Today’s Defenses Are Failing Against Evolving Threats appeared first on MedCity News.
Millie’s Series A round was co-led by TMV and Foreground Capital. The financing will help the company expand its offerings and footprint. The post Millie Raises $12M to Advance Maternal Healthcare appeared first on MedCity News.
The Massachusetts attorney general sued UnitedHealthcare, alleging the insurer improperly inflated MassHealth members’ health risk scores to secure at least $100 million in excess payments. The post Massachusetts Attorney General Sues UnitedHealthcare, Alleges $100M MassHealth Fraud appeared first on MedCity News.
It’s critical that healthcare organizations delivering on the program’s promise not be torpedoed by the “bad actors” The post The Case for 340B Done Right appeared first on MedCity News.
That is the tile of my recent paper in the Journal of Medical Economics with co-authors Kyi-Sin Than, Sanjana Muthukrishnan, Jincy Paulose, Ver Bilano and Nicholas Kuypers. The abstract is below: ObjectiveParoxysmal nocturnal hemoglobinuria (PNH) is a rare and debilitating hematological disease with significant economic burden. Despite the availability of multiple therapies, there is a…
This tracker provides up-to-date information on countries with signed bilateral MOU global health agreements with the U.S.
Though anselamimab failed its Phase 3 test in light chain amyloidosis, AstraZeneca points to encouraging results in a pre-defined patient subgroup — which may not be a winning strategy. Prothena resurrected its failed drug candidate for the disease based on a subgroup analysis, only to see that antibody fall short in a pivotal study. The…